Epsilon M&A Deal Report - Laboratoire Polidis
Transaction Multiples for the Valuation of Private Companies
Private group led by Siparex Entrepreneurs, UI Investissement / Laboratoire Polidis
No EMAT :
120574
Announced Date :
24/01/2025
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private group led by Siparex Entrepreneurs, UI Investissement
Target :
Laboratoire Polidis
Country :
Hauts-De-Seine
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Founded in 1986, Laboratoire Polidis specialises in the development and marketing of medical devices. > Develops and markets a portfolio of more than 30 products and 200 SKUs, covering pain relief...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Food Complements » = 123
| Date | Acquirer | Target | Country | Multiples | See details |
| 06/08/2020 | METRO France | Filpromer | Manche | *** | 119813 |
| 12/03/2024 | Private group led by FrenchFood Capital, Finorpa, Bpifrance, BNP Paribas Développement, Jacana Invest | Ets JC DAVID | Pas-De-Calais | * | 119787 |
Source: Epsilon Research / EMAT
